Clin2
NCT06770478Possibly a fitRecruiting

New PET scan to improve tumor imaging before surgery

Tumour of Epithelial Origin68Ga-MY6349

Part of Cancer clinical trials.

This study tests a new PET/CT scan (68Ga-MY6349) to see how well it finds tumors before surgery. If you have a confirmed tumor that your doctor plans to remove, the scan might give a clearer picture to guide the operation.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 80 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have a tumor confirmed by biopsy, and your doctor plans to remove or explore it with surgery.
  • You are expected to live at least 3 more months, in your doctor’s opinion.
  • You are willing and able to follow the study schedule and sign a consent form.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06696326Recruiting
New PET scan for prostate cancer detection

This study tests a new type of PET/CT scan that uses a special tracer (68Ga-MY6349) to better see prostate cancer in the body. It may help doctors find cancer that has come back or spread, so you can get the right treatment sooner.

Xiamen, Fujian
NCT07144748Recruiting
New PET/CT scan for finding cancer

This study uses a special PET/CT scan (called 68Ga-NYM096) to see if it can help find different types of cancer. The scan may help doctors get clearer pictures of where cancer is in your body.

Beijing
NCT07045428Not yet recruiting· Phase 1
Gallium scan for solid tumors before surgery

This trial tests a special imaging agent called 68Ga-GP-01 to see if it can help find cancer in people with solid tumors. You would get a PET scan before surgery to see where the cancer is.

NCT07046702Recruiting
PET scan using a new tracer for solid tumors

This study tests whether a new imaging agent called 68Ga-MY6349 can help detect tumors during a PET/CT scan. If you are an adult with a solid tumor (newly diagnosed or already treated), you may be able to take part in this research to see if the new tracer works better than standard imaging.

Xiamen, Fujian
NCT07593976Recruiting· Phase 2
New PET scan to predict breast cancer treatment response

This study tests a new type of PET scan (a specialized imaging test) to see if it can predict whether chemotherapy will work for HER2-positive breast cancer before surgery. The scan uses a radioactive tracer designed to highlight HER2-positive cancer cells, helping doctors personalize your treatment plan.

Rouen
NCT07144085Recruiting· Phase 1
Testing a new PET scan tracer for cancer diagnosis

This trial tests a new type of PET/CT scan that uses a special tracer (called ⁶⁸Ga-FXX489) to help find and diagnose cancers. It is for people who are strongly suspected to have cancer and want to see if this new imaging method can help their doctors learn more about their disease.

Shenyang, Liaoning

Hear when a new Tumour of Epithelial Origin trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.